Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-19T16:36:08.749Z Has data issue: false hasContentIssue false

Plasma Lipids and Lipoproteins in Friedreich's Ataxia and Familial Spastic Ataxia — Evidence for an Abnormal Composition of High Density Lipoproteins

Published online by Cambridge University Press:  18 September 2015

Y. S. Huang
Affiliation:
Clinical Research Institute of Montreal and l'Hôpital de l'Enfant Jésus, Quebec
A. C. Nestruck
Affiliation:
Clinical Research Institute of Montreal and l'Hôpital de l'Enfant Jésus, Quebec
A. Barbeau*
Affiliation:
Clinical Research Institute of Montreal and l'Hôpital de l'Enfant Jésus, Quebec
J. P. Bouchard
Affiliation:
Clinical Research Institute of Montreal and l'Hôpital de l'Enfant Jésus, Quebec
J. Davignon
Affiliation:
Clinical Research Institute of Montreal and l'Hôpital de l'Enfant Jésus, Quebec
*
Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, Quebec, Canada, H2W 1R7
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A systematic study of plasma lipids and lipoproteins was carried out in II cases of Friedreich's ataxia and 6 cases of familial spastic ataxia (Charlevoix-Saguenay disease) using II healthy normolipidemic volunteers of comparable age and sex as controls. No differences were noted in the fatty acid profile of the total lipid fraction, in the total cholesterol and phospholipids or in the percentage distribution of the individual phospholipid classes. The triglycerides were significantly higher in Friedreich's ataxia, but remained within the normal range. Although no systematic abnormalities could be detected in the electrophoretic pattern of plasma lipoproteins or in the apolipoprotein profile on polyacrylamide gel electrophoresis, major differences were found in the high density lipoprotein (HDL) fraction. Their total amount was reduced and their composition was abnormal in both neurological diseases. In Friedreich patients, the relative proportion of cholesterol and triglycerides was increased while the relative protein content was greatly reduced. In Charlevoix disease, a similar abnormality was seen except for the excess of triglycerides. The proportion of phospholipids in HDL was the same in the three groups of patients. In addition, the low density lipoprotein (LDL) fraction was slightly reduced in both diseases. This anomaly of the HDL fraction could indicate that the HDL apolipoprotein moiety has a greater affinity for cholesterol and triglycerides in Friedreich's ataxia than its normal counterpart.

Type
Quebec Cooperative Study of Friedreich's Ataxia
Copyright
Copyright © Canadian Neurological Sciences Federation 1978

References

REFERENCES

Aubry, F., Lapierre, Y., Noel, C. and Davignon, J. (1971). Ultracentriftjgal demonstration of floating beta-lipoprotein in type III hyperlipoproteinemia. Diagnostic value. Ann. Intern. Med. 75, 231237.Google Scholar
Bachorik, P. S., Kwiterovich, P. D. and Simon, A. (1974). Resolubilization of certain apoprotein components of human plasma high density lipoproteins in TCA-fixed polyacrylamide gels during destaining in acetic acid solutions. Anal. Biochem. 60, 631636.Google Scholar
Barbeau, A. (1976). Friedreich’s ataxia 1976 — An overview. Can. J. Neurol. Sci. J. 3, 389397.Google Scholar
Barbeau, A., Breton, G., Lemieux, B. and Butterworth, R. F. (1976). Bilirubin metabolism in Friedreich’s ataxia — Preliminary investigation. Can. J. Neurol. Sci. 3. 365372.Google Scholar
Bartlett, G.R. (1959). Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466468.CrossRefGoogle ScholarPubMed
Block, W.D.. Jarrett, K. J. and Levine, J. B. (1966). An improved automated determination of serum total cholesterol with a single color reagent. Clin. Chem. 12, 681689.Google Scholar
Bolton, C.H., Hampton, J.R. and Phillipson, O.T. (1968). Platelet behaviours and plasma phospholipids in multiple sclerosis. Lancet; 1, 99104.CrossRefGoogle ScholarPubMed
Boon, J., Broekhuyse, R.M.. Vanmunster, P. and Schretlen, E. (1969). Abnormal pattern of the phospholipids of plasma and erythrocytes in four children with obstructive jaundice with abnormal spontaneous hemolysis. Clin. Chim. Acta 23. 453456.Google Scholar
Bouchard, J. P. et al. This issue.Google Scholar
Bragdon, J. H. (1960). Methods for extraction of serum lipids. In: Lipids and the steroid hormones in clinical medicine, (Sunderman, F. W., ed). J. B. Lippincott Co., Philadelphia.Google Scholar
Cooper, R.A., Arner, E.C, Wiley, J. S. and Shattil, S. J. (1975). Modification of red cell membrane structure by cholesterolrich lipid dispersions: a model for the primary spur cell defect. J. Clin. Invest. 55, 115126.Google Scholar
Davignon, J. (1977). Current views on the etiology and pathogenesis of atherosclerosis. In: Hypertension, physiopathology and treatment, (Genest, J., Koiw, E. and Kuchel, O.,’eds). McGraw-Hill Book Co., New York, pp. 961989.Google Scholar
Davignon, J. and Langelier, M. (1971). Electrophorèse et ultra-centrifugation combinées dans le diagnostic des hyperlipidémies primaires. Union Med. Can. 100, 21202128.Google Scholar
Ekman, R. and Nilsson-Ehle, P. (1975). Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue. Clin. Chim. Acta 63, 2935.Google Scholar
Fessel, W.J. (1971). Fat disorders and peripheral neuropathy. Brain 94, 531540.Google Scholar
Folch, J., Lees, M. and Sloane-Stanley, G. H. (1957). A simple method for the isolation of purification of total lipids from animal tissues. J. Biol. Chem. 226, 497509.Google Scholar
Fredrickson, D.S., Gotto, A.M. and Levy, R.I. (1972). Familial lipoprotein deficiency (abetalipoproteinemia. hypobetalipoproteinemia and Tangier disease). In: The metabolic basis of inherited disease. 3rd edition. (Stanbury, J. B.. Wyngaarden, J. B. and Fredrickson, D.S. eds). McGraw-Hill, New York, pp. 498530.Google Scholar
Fredrickson, D.S.. Levy, R.I. and Lees, R.S. (1967). Fat transport in lipro-proieins — an integrated approach to mechanisms and disorders. New Eng. J. Med. 276. 32–44. 94–103, 148–156, 215–226, 273–281.Google Scholar
Gillett, M.P.T. and Besterman, E.M.M. (1975). Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseases. Atherosclerosis 22, 111124.Google Scholar
Glomset, J.A. (1972). Plasma lecithin: cholesterol acyltransferase. In: Blood lipids and lipoproteins: quantitation, composition and metabolism, (Nelson, G.J., ed). Wiley Interscience, New York, pp. 745787.Google Scholar
Hatch, F.T. and Lees, R.S. (1968). Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6, 168.Google Scholar
Havel, R.J., Eder, H.A. and Brag-Don, J.H. (1955). The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34. 13451353.Google Scholar
Heilman, K.M. and Fisher, W. R. (1974). Hyperlipidemic dementia. Arch. Neurol. 31, 6768.Google Scholar
Kane, J.P. (1973). A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins. Anal. Biochem. 53, 350364.CrossRefGoogle ScholarPubMed
Kane, J.P., Sata, T.. Hamilton, R.L. and Havel, R.J. (1975). Apoprotein composition of very low density lipoproteins of human serum. J. Clin. Invest. 56, 16221634.Google Scholar
Kraml, N. and Cosyns, L. (1969). A semi-automated determination of serum triglycerides. Clin. Biochim. 2. 373380.CrossRefGoogle Scholar
Laurell, S. (1966). Method for routine determination of plasma triglycerides. Scand. J. Clin. Lab. Invest. 18 , 668672.Google Scholar
Lees, R.S. and Hatch, F.T. (1963). Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J. Lab. Clin. Med. 61. 518528.Google Scholar
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265275.Google Scholar
Mars, H., Lewis, L.A., Robertson, A.L., Butkus, A. and Williams, G.H. Jr. (1969). Familial hypo-β -lipopro-teinemia — a genetic disorder of lipid metabolism with nervous system involvement. Amer. J. Med. 46, 886900.Google Scholar
Metcalfe, L.D.. Schmidts, A.A. and Pelk, J.R. (1966). Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis. Anal. Chem. 38. 514515.Google Scholar
Mishkel, M. A. and Spritz, N. (1969). The effect of trans-isomerized trilinolein on plasma lipids of man. In: Drugs affecting lipid metabolism, (Holmes, W.L., Carlson, L. A. and Paoletti, R. eds). Plenum Press, New York, pp. 355364.Google Scholar
Mueller, P.S. and Quick, D.T. (1970). Studies of glucose, insulin and lipid metabolism in amyotrophic lateral sclerosis and other neuromuscular disorders. J. Lab. Clin. Med. 76. 190201.Google Scholar
Noel, C, Marcel, Y.L. and Davignon, J. (1972). Plasma phospholipids in the different types of primary hyperlipoproteinemia. J. Lab. Clin. Med. 79, 611621.Google ScholarPubMed
Pilecki, R., Samochowiec, L. and Szyszka, K. (1975). The influence of atherogenic diet and “essential” phospholipids upon the contents of noradrenaline and dopamine in the brain of rats and their exploratory activity. Atherosclerosis 22, 401410.Google Scholar
Sandbank, U., Bechar, M. and Bornstein, B. (1971). Hyperlipemic polyneuropathy. Acta Neuropath. 19, 290300.CrossRefGoogle Scholar
Sandbank, U. and Bubis, J.J. (1973). Hyperlipaemic neuropathy — Experimental study. Brain 96, 335358.Google Scholar
Scanu, A.M. and Edelstein, C. (1971). Solubility in aqueous solution of ethanol of the small molecular weight peptides of the serum very low density and high density lipoprotein. Relevance to the recovery problem during delipidation of serum lipoproteins. Anal. Biochem. 44, 576588.Google Scholar
Shapiro, A.L., Vinuela, , and Maizel, J.V. Jr. (1967). Molecular weight estima-tion of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem. Biophys. Res. Commun. 28, 815820.Google Scholar
Sidbury, J.B. Jr., Smith, E.K. and Harlan, W. (1967). An inborn error of short-chain fatty acid metabolism. J. Pediatrics 70, 815.Google Scholar
Steinbberg, D. (1972). Phytanic acid storage disease: Refsum’s syndrome. In: The metabolic basis of inherited disease, (Stanbury, J.B., Wyngaarden, J.B. and Fredrickson, D.S., eds). McGraw-Hill, New York. pp. 833853.Google Scholar
Weber, K. and Osborn, M. (1969). The reliability of molecular weight determina-tions by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Biol. Chem. 244, 44064412.Google Scholar